MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Avita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 13% sequentially from $19.3 million in the first quarter and 18% from $18.4 million a year earlier, as the wound-care company cited growth across its product portfolio and in U.S. and international markets.
Presid
Avita Medical (NASDAQ:RCEL) expects continued sequential revenue growth and aims to reach cash flow breakeven in the fourth quarter of 2025, President and CEO Cary Vance said at the Canaccord 46th Annual Boston Growth Conference.
Vance, who has been CEO for about 10 months after previously serving
Rani Therapeutics (NASDAQ:RANI) outlined its strategy to expand the use of its RaniPill oral biologic-delivery platform through a mix of technology partnerships, selectively licensed product programs and investments in manufacturing capacity.
Chief Executive Officer Talat Imran described the clinic
QuickLogic (NASDAQ:QUIK) is targeting aerospace, defense and other long-life infrastructure applications as it expands its programmable logic offerings, President and CEO Brian Faith said during a Canaccord Genuity discussion.
Faith described programmable logic as a semiconductor segment experienci
Quanterix (NASDAQ:QTRX) CEO Everett Cunningham said the company is repositioning its commercial organization and investing in diagnostics and clinical-trial capabilities following the integration of Akoya Biosciences, while acknowledging continued pressure in academic, government and biopharma marke
Qualys (NASDAQ:QLYS) executives said the company’s second-quarter performance reflected growing customer demand for vulnerability remediation, patch management and Enterprise TruRisk Management, or ETM, while positioning newer products as potential drivers of longer-term growth.
During an investor
The Metals Company faces a licensing delay to October, but analysts remain optimistic as revenue could begin in late 2027 amid growing US national security interest in deep-sea mining.
Palvella Therapeutics (NASDAQ:PVLA) is advancing topical therapies for serious rare skin diseases and vascular malformations that lack FDA-approved treatments, with its lead candidate, QTORIN rapamycin, moving toward a planned New Drug Application submission for microcystic lymphatic malformations.
OneSpaWorld posted record Q2 revenue and adjusted earnings, raised full-year guidance, and retains an analyst Buy rating, though it remains heavily dependent on the cruise industry.
PTC Therapeutics (NASDAQ:PTCT) plans to acquire the ST-920 Fabry disease gene therapy asset through a competitive bankruptcy auction, positioning the company to add a potential one-time treatment to its rare disease portfolio while using its existing global commercial and regulatory infrastructure.
Meta Platforms and Tesla show improving RSI readings after recent selloffs, with both Magnificent Seven stocks facing earnings volatility but analysts still forecasting double-digit upside ahead.
People Incorporated Common Stock (NASDAQ:PPLI) is focusing its capital allocation on its MGM minority stake and its People media business while seeking new homes for several non-core assets, Chief Financial Officer Tim Quinn said during a fireside chat.
Quinn said the former IAC has identified MGM
Pulse Biosciences (NASDAQ:PLSE) is positioning its nanosecond pulsed field ablation technology as a potential next-generation treatment platform for atrial fibrillation and other conditions, President, CEO and Co-Chairman Paul LaViolette said during the Canaccord Genuity 46th Annual Global Growth Co
Affiliated Managers Group posted record Q2 revenue, earnings, and assets under management, driven by an alternatives push, though shares trading near consensus price targets suggest limited further upside.
Pagaya Technologies (NASDAQ:PGY) CFO Jonathan Dobres outlined the company’s growth strategy, funding model and profitability trajectory at the 46th Annual Canaccord Growth Conference, emphasizing expansion with existing lending partners as well as new partner additions.
Dobres described Pagaya as a
Microsoft plans to unveil its Maia 300 AI chip in September, seeking TSMC capacity for over 300,000 units by 2027 as it aims to reduce reliance on NVIDIA processors.
HGER, MCHI, and VFLO have posted strong summer returns by targeting commodities, Chinese equities, and free-cash-flow-rich growth stocks, respectively, amid inflation and rate uncertainty.
Progyny (NASDAQ:PGNY) CEO Pete Anevski said the company expects member engagement and utilization to rebound following a more pronounced summer seasonal slowdown, while early renewal and new-client commitments have increased management’s confidence in its outlook for the remainder of the year.
Spea
Perion Network (NASDAQ:PERI) is positioning its Perion One platform as an AI-enabled layer designed to help advertisers manage campaigns across a fragmented digital advertising market, Chief Executive Officer Tal Jacobson said during a Canaccord Genuity discussion.
Jacobson said advertisers are see
Pegasystems (NASDAQ:PEGA) COO and CFO Ken Stillwell said the company is positioning its platform around enterprise workflows that require consistent, governed and predictable outcomes, particularly in regulated or control-heavy environments.
Speaking at Oppenheimer’s 29th Annual Technology Conferen
Pegasystems (NASDAQ:PEGA) CFO Ken Stillwell outlined the company’s position as a workflow platform for large enterprises, its expanding AI product capabilities and its plans to improve sales execution following a softer first half for annual contract value growth.
Speaking at a Canaccord fireside c
Pacific Biosciences of California (NASDAQ:PACB) reported second-quarter revenue of $39 million, including $20 million in consumables revenue, $13 million in instrument revenue and $6 million in services revenue, CFO Jim Gibson said during the Canaccord Genuity Growth Conference.
Revenue increased s
Ouster (NASDAQ:OUST) executives said the company expects its recently launched Rev8 lidar platform to become the core of its sensing business over the next several years, supported by early multimillion-dollar orders and a broader push into software, cameras and sensor fusion.
Speaking at an Oppenh
onsemi (NASDAQ:ON) executives said the company is increasing factory utilization to meet stronger demand in AI data center markets while maintaining its longer-term focus on automotive and industrial customers.
Speaking at a KeyBanc Capital Markets event, President and CEO Hassane El-Khoury said th
Universal Display (NASDAQ:OLED) President and CEO Steve Abramson said the OLED industry’s continued investment in new manufacturing capacity reflects panel makers’ confidence in long-term adoption, even as smartphone demand faces near-term pressure from higher component and memory costs.
Speaking a
Orthofix Medical (NASDAQ:OFIX) executives said the company’s updated outlook reflects the restoration of bone growth stimulation reimbursement, improving trends in biologics and limb reconstruction, and an expected European inventory order, partly offset by a steeper-than-anticipated decline among s
Ocugen (NASDAQ:OCGN) is positioning its ophthalmology gene therapy portfolio around treatments for inherited retinal diseases and dry age-related macular degeneration, with pivotal-stage programs in retinitis pigmentosa, Stargardt disease and geographic atrophy, Chairman, CEO and Co-Founder Shankar
NXP Semiconductors (NASDAQ:NXPI) sees a meaningfully improved business environment compared with 90 days ago and a year ago, with book-to-bill ratios solidly above one across its end markets, according to Senior Vice President of Investor Relations Jeff Palmer.
Speaking at a KeyBanc Capital Markets
Natera (NASDAQ:NTRA) Chief Financial Officer Mike Brophy said the company delivered strong second-quarter momentum across its women’s health, oncology and organ health businesses, citing record Signatera volumes, continued revenue and average selling price strength, improved gross margins and narrow
Insight Enterprises (NASDAQ:NSIT) is targeting growth in artificial intelligence infrastructure and AI services while seeking to improve operating efficiency under its newly introduced three-year “One Insight” plan, CEO Jack Azagury said during a discussion hosted by Canaccord.
Azagury, who joined
Terra Innovatum Global S.R.L. (NASDAQ:NKLR) said it is advancing licensing and construction preparations for its SOLO nuclear microreactor, with the company targeting a first-of-a-kind deployment in Illinois by late 2027 and commercial operations in 2028.
Speaking at Canaccord Genuity’s 46th Annual
Nexxen International (NASDAQ:NEXN) outlined its commercial priorities following a series of executive appointments, highlighting its end-to-end advertising technology platform, connected TV growth, enterprise customer expansion and investments in artificial intelligence.
Chance Johnson, who was new
NioCorp Developments (NASDAQ:NB) detailed its recently published 2026 technical report for the Elk Creek Critical Minerals Project in Nebraska, outlining an expanded product suite, updated mine design and projected economics for the proposed underground mining and processing operation.
Mark Smith,
Nature's Sunshine Products (NASDAQ:NATR) outlined a strategy to double sales to $1 billion and expand EBITDA margins to 15%, with Chief Executive Officer Ken Romanzi pointing to geographic expansion, digital and retail channel development, marketing initiatives and acquisitions as the company’s prim
Truist Securities upgraded Best Buy to Buy with a $95 price target, citing rising sales of AI-enabled gadgets ahead of the retailer's earnings report due later this month.
Everspin Tech (NASDAQ:MRAM) outlined plans to expand its MRAM memory product portfolio, manufacturing footprint and revenue base during an Oppenheimer presentation, with management targeting more than $100 million in annual revenue by fiscal 2029.
President and CEO Sanjeev Aggarwal said Everspin de
Applied Materials beat Q3 estimates and raised guidance, but shares fell 6% as sequential growth slowed and gross margin guidance stalled at 50.4% for Q4.
Intuitive Machines missed Q2 revenue and EPS estimates, but its $1.8 billion backlog, analyst Buy ratings, and institutional buying point to a path toward profitability.
Monro Muffler Brake (NASDAQ:MNRO) shareholders elected eight directors, approved an advisory vote on named executive officer compensation and ratified PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm at the company’s 2026 annual meeting.
The virtual meeting
Texas Roadhouse and Brinker International shares have rallied on easing beef costs, stronger comps, and improved margin trends, with Brinker also raising its fiscal 2027 guidance.
Merit Medical Systems (NASDAQ:MMSI) is focused on completing the objectives of its current long-range plan while developing its next strategic framework, Chief Financial Officer and Treasurer Raul Parra said during a Canaccord investor event.
Parra said the company remains “hyper-focused” on execut
AirJoule Technologies faces record short interest amid cash burn concerns, but rising Kubota deployments, UL certification progress, and analyst Buy ratings suggest a possible short squeeze ahead.
Merit Medical Systems (NASDAQ:MMSI) is preparing its next long-range plan as the medical-device company works through a leadership transition, updates its reporting structure and seeks to build on recent revenue and margin momentum.
Speaking at Bank of America’s virtual SMID Cap event, Chief Financ
Stocks eye a third winning week as strong earnings from SoundHound, Albemarle and CAVA offset mixed results, with MarketBeat analysts covering NVIDIA, Lockheed Martin, GE Vernova and more.
Magnite (NASDAQ:MGNI) is positioning itself as a key infrastructure provider for programmatic connected-TV advertising as streaming platforms, television manufacturers and commerce-media businesses seek technology partners to manage inventory, data and demand, according to Head of Investor Relations
Madrigal Pharmaceuticals (NASDAQ:MDGL) said Rezdiffra continued to post strong commercial growth in the second quarter of 2026, while the company expanded its development pipeline around the MASH therapy and prepared for several potential clinical catalysts.
Speaking at a Canaccord Genuity event, C
Mobileye Global (NASDAQ:MBLY) said inventory held by its Tier 1 customers stood at roughly five weeks, compared with a typical range of four to five weeks, as automakers maintain somewhat higher safety stock amid supply-chain constraints.
Speaking at Canaccord Genuity’s growth conference, Chief Com
908 Devices (NASDAQ:MASS) is sharpening its focus on handheld chemical and drug detection systems for public safety, defense and law enforcement following the divestiture of its bioprocessing and biopharma business line, executives said during a Canaccord Genuity discussion.
Chief Executive Officer
Pulmonx (NASDAQ:LUNG) is rebuilding its sales organization, targeting a return to growth and preparing for potential commercialization of its AeriSeal therapy outside the United States in the second half of next year, President and CEO Glen French said during a Canaccord fireside chat.
French, who
Lucid Diagnostics (NASDAQ:LUCD) is positioning its EsoGuard test as a non-invasive tool to identify Barrett’s Esophagus, a precancerous condition associated with esophageal cancer, while it awaits a key Medicare coverage decision and expands relationships with commercial payers, the Department of Ve
Lantronix (NASDAQ:LTRX) has repositioned its business around “edge intelligence” products that combine computing and connectivity, with aerospace and defense, critical-infrastructure monitoring and enterprise markets serving as its three primary verticals, President and CEO Saleel Awsare said during
Lattice Semiconductor (NASDAQ:LSCC) CFO Lorenzo Flores said the company is seeing rising demand from both AI-focused and general-purpose server deployments, supported by increasing FPGA content per server and higher average selling prices.
Speaking at a KeyBanc Capital Markets event, Flores said in
Kopin (NASDAQ:KOPN) is expanding its focus on MicroLED displays for defense applications and AI data-center interconnects, Chief Executive Officer Michael Murray said during a discussion hosted by Canaccord Genuity Senior Aerospace and Defense Technology Analyst Austin Moeller.
Murray said the 40-y
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) said its commercialized recurrent pericarditis treatment ARCALYST continues to grow, while the company has begun a pivotal Phase 3 study of follow-on candidate KPL-387.
Speaking at a Canaccord Genuity event, Chief Operating Officer Ross Moat said
Commerce.com Chief Financial Officer and Chief Operating Officer Daniel Lentz outlined the company’s strategy to expand its role in e-commerce discovery, data orchestration and B2B operations during the Oppenheimer TMT Conference, citing the growing influence of artificial intelligence-based search
Kaltura (NASDAQ:KLTR) outlined its effort to expand beyond video content management into what Chief Executive Officer Ron Yekutiel called “agentic digital experiences,” combining the company’s video infrastructure with conversational AI, avatars, personalized content and interactive interfaces.
Spe
Corvex reported $3.8 million in second-quarter 2026 revenue, its first full reporting period including the AI cloud computing business acquired through its March merger with Corvex Legacy Holdings. Company leaders said the quarter’s reported revenue reflected the amount of computing capacity that wa
Sidus Space (NASDAQ:SIDU) reported lower second-quarter revenue while strengthening its cash position through two equity offerings that generated $158.5 million in gross proceeds during the quarter. Management said the company is shifting its focus from technology demonstrations toward customer adop
OrthoPediatrics (NASDAQ:KIDS) reported record revenue, adjusted EBITDA and number of children helped during the second quarter, as the pediatric orthopedic device company began to see early contributions from its newer “super cycle” products, Chief Executive Officer Dave Bailey said at the Canaccord
Solana (NASDAQ:HSDT) reported second-quarter 2026 revenue of $2.5 million, driven primarily by staking rewards from its digital asset treasury, as the company continued building its institutional advisory, validator infrastructure and treasury businesses across Asia-Pacific.
The company said it gen
J.B. Hunt Transport Services (NASDAQ:JBHT) executives said the company sees a strengthening freight environment, supported by tightening capacity, improving truckload pricing and sustained rail service quality, while emphasizing that intermodal pricing opportunities may build into 2027.
Speaking at
Contango ORE (NYSEAMERICAN:CTGO), which management referred to during its quarterly update as Contango Silver & Gold, said it expects stronger production, lower costs and increased cash distributions in the second half of 2026 as mining advances into higher-grade material at the Manh Choh joint
Itron (NASDAQ:ITRI) executives said at Oppenheimer’s Annual Technology Conference that the company’s opportunity is increasingly tied to grid-edge intelligence, software and services rather than its historical identity as a smart-meter supplier.
Chief Financial Officer Joan Hooper said Itron’s earl
Innate Pharma (NASDAQ:IPHA) said it has raised €30 million in equity financing, providing funding to advance its strategic priorities, including the development of its lacutamab and IPH4502 programs and its preclinical antibody-drug conjugate, or ADC, portfolio.
Chief Executive Officer Jonathan Dic
Braskem (NYSE:BAK) reported recurring EBITDA of $1.043 billion for the second quarter of 2026, supported by wider international petrochemical spreads following supply disruptions linked to the Middle East conflict. The company said the improvement was tactical rather than evidence of a structural re
Elite Pharmaceuticals (OTCMKTS:ELTP) reported first-quarter fiscal 2027 revenue of $32.4 million and operating profit of $7.5 million, with Chief Financial Officer Carter Ward describing both measures as steady and consistent with the preceding three quarters.
The quarter ended June 30, 2026, and E
IDEXX Laboratories (NASDAQ:IDXX) outlined an innovation-led growth strategy at its 2026 Investor Day, highlighting a $45 billion global companion-animal testing opportunity, expanded commercial investments and a pipeline of diagnostic, software and artificial-intelligence offerings intended to incre
Wesdome Gold Mines (TSE:WDO) reported second-quarter net income of C$94 million and free cash flow of C$42 million, while outlining longer-term plans to expand production capacity, extend mine lives and pursue exploration opportunities around its Eagle River and Kiena operations.
President and CEO
Tidewater Midstream and Infrastructure (TSE:TWM) raised its 2026 adjusted EBITDA outlook after reporting record second-quarter consolidated adjusted EBITDA, supported by strong refining and renewable diesel market conditions, higher facility utilization and debt reduction.
During a joint second-qua
Aya Gold & Silver (TSE:AYA) reported higher production, revenue and cash flow for the second quarter of 2026, supported by increased throughput at its Zgounder mine in Morocco and continued contributions from its Boumadine tailings reclamation operation.
President and Chief Executive Officer Benoit
VerticalScope (TSE:FORA) reported second-quarter 2026 revenue of $13.8 million, down 5% from a year earlier but up 20% sequentially, as the company cited improving programmatic advertising trends, growth in paid audience acquisition and expanding AI-driven commerce initiatives.
Adjusted EBITDA rose
High Liner Foods (TSE:HLF) reported higher second-quarter sales volume and adjusted EBITDA as management cited resilient seafood demand, retail momentum and progress in pricing, promotional discipline and supply-chain execution. The company also recorded tariff recoveries that management said provid
Leatt (OTCMKTS:LEAT) reported second-quarter revenue that rose modestly from a year earlier as delayed shipments to global distributors offset gains in U.S. sales, direct-to-consumer business, body armor and helmets.
Total revenue for the quarter ended June 30 was $16.39 million, up 1% from $16.18
Automotive Properties Real Est Invt TR (TSE:APR.UN) reported higher revenue, net operating income and adjusted funds from operations in the second quarter of 2026, supported by acquisitions completed during 2025 and the first quarter as well as partial-period contributions from three properties acqu
Sinda (NYSE:SIND) outlined plans to accelerate drilling, advance an underground exploration decline and update its mineral resource estimate by the end of 2026, as the silver exploration company held its first earnings call following its June listing on the New York Stock Exchange.
Executive Chairm
